SOURCE: Corporate Profile LLC

Corporate Profile LLC

September 17, 2010 08:00 ET

Corporate Profile's CPReports.com Publishes Gene Marcial's Investor Alert for Radient Pharmaceuticals

NEW YORK, NY--(Marketwire - September 17, 2010) -  Corporate Profile's newest financial website, CPReports.com, announces an Investor Alert by Gene Marcial discussing Radient Pharmaceuticals (NYSE Amex: RPC). See full article at http://www.cpreports.com or http://www.cpreports.com/?p=493

About Radient Pharmaceuticals:

Headquartered in Tustin, California, Radient Pharmaceuticals is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its Onko-Sure® In Vitro Diagnostic cancer test. The company's focus is on the discovery, development and commercialization of unique high-value diagnostic tests that help physicians answer important clinical questions related to early disease detection; treatment strategy; and the monitoring of disease progression, prognosis, and diagnosis to ultimately improve patient outcomes. Radient Pharmaceuticals' current Onko-Sure® cancer test is used to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, perform additional testing, or assist in the selection of therapy. For more information www.radient-pharma.com.

About CPReports.com

CPReports.com features Gene Marcial's Inside Wall Street Newsletter, published three times a week exclusively on www.CPReports.com. The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary that they won't get anywhere else. Content is focused on what is going on in the stock market and on Wall Street, including stories about large-capitalization as well as small-cap companies, both on the long and short side.

About Corporate Profile.com

www.CorporateProfile.com is a broadcasting website where Fashion meets Finance, merging two mainstream industries results in the unique platform for today's hottest tips and market info.

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation.